ANDREW A WOLFF Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANDREW A WOLFF.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANDREW A WOLFF. ANDREW A WOLFF is SVP Clinical R&D, CMO in CYTOKINETICS INC ($CYTK).
Latest Insider Trading Transactions of ANDREW A WOLFF
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 05 2013 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | M | 0.00 | 14,583 | 0 | 0 | |
| Sep 05 2013 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Payment of Exercise | F | 7.65 | 5,479 | 41,914 | 20,637 | 26.1 K to 20.6 K (-20.98 %) |
| Sep 05 2013 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Buy | M | 0.00 | 14,583 | 0 | 26,116 | 11.5 K to 26.1 K (+126.45 %) |
| Mar 07 2013 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 1.00 | 130,897 | 130,897 | 130,897 | |
| Mar 07 2013 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 1.00 | 119,103 | 119,103 | 119,103 | |
| Sep 05 2012 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | M | 0.00 | 87,500 | 0 | 87,500 | |
| Sep 05 2012 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Payment of Exercise | F | 0.76 | 32,052 | 24,353 | 66,698 | 98.8 K to 66.7 K (-32.46 %) |
| Sep 05 2012 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Buy | M | 0.00 | 87,500 | 0 | 98,750 | 11.3 K to 98.8 K (+777.78 %) |
| Mar 07 2012 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 1.05 | 116,335 | 122,152 | 116,335 | |
| Mar 07 2012 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 1.05 | 58,665 | 61,598 | 58,665 | |
| Nov 21 2011 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 0.00 | 175,000 | 0 | 175,000 | |
| Mar 01 2011 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 1.57 | 141,664 | 222,412 | 141,664 | |
| Mar 01 2011 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 1.57 | 58,336 | 91,588 | 58,336 | |
| Feb 26 2010 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 3.08 | 92,916 | 286,181 | 92,916 | |
| Feb 26 2010 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 3.08 | 42,084 | 129,619 | 42,084 | |
| Mar 02 2009 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 1.85 | 92,083 | 170,354 | 92,083 | |
| Mar 02 2009 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 1.85 | 37,917 | 70,146 | 37,917 | |
| Mar 04 2008 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 3.37 | 97,065 | 327,109 | 97,065 | |
| Mar 04 2008 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 3.37 | 27,935 | 94,141 | 27,935 | |
| Mar 16 2007 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 6.81 | 40,815 | 277,950 | 40,815 | |
| Mar 16 2007 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 6.81 | 14,185 | 96,600 | 14,185 | |
| Mar 03 2006 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 7.15 | 42,981 | 307,314 | 42,981 | |
| Mar 03 2006 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 7.15 | 17,019 | 121,686 | 17,019 | |
| Apr 13 2005 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 6.59 | 11,719 | 77,228 | 11,719 | |
| Apr 13 2005 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 6.59 | 781 | 5,147 | 781 | |
| Oct 21 2004 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 9.91 | 69,640 | 690,132 | 69,640 | |
| Oct 21 2004 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 9.91 | 40,360 | 399,968 | 40,360 | |
| Oct 21 2004 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 9.91 | 69,640 | 690,132 | 69,640 | |
| Oct 21 2004 | CYTK | CYTOKINETICS INC | WOLFF ANDREW A | SVP Clinical R&D, C ... | Option Exercise | A | 9.91 | 40,360 | 399,968 | 40,360 |
Page: 1